{"id":317,"date":"2020-06-16T22:49:32","date_gmt":"2020-06-16T22:49:32","guid":{"rendered":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/?post_type=press-release&p=317"},"modified":"2024-05-07T19:09:06","modified_gmt":"2024-05-07T19:09:06","slug":"ona-therapeutics-raises-e30m-in-series-a-financing","status":"publish","type":"press-release","link":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-raises-e30m-in-series-a-financing\/","title":{"rendered":"Ona Therapeutics raises \u20ac30M in Series A financing"},"content":{"rendered":"

Barcelona, Spain, June 16th 2020: <\/strong>\u00a0Ona Therapeutics, which is focused on the discovery and development of therapeutic biologics to treat metastatic cancer,\u00a0 announces today the closing of a \u20ac30 million Series A financing, with participation from existing investor Asabys Partners and new investors Alta Life Sciences, Bpifrance \u2013 InnoBio 2, Fund+ and Ysios Capital.<\/p>\n

See more details in the press release here<\/a><\/p>\n","protected":false},"template":"","class_list":["post-317","press-release","type-press-release","status-publish","hentry"],"acf":[],"yoast_head":"\nOna Therapeutics | Ona Therapeutics raises \u20ac30M in Series A financing<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-raises-e30m-in-series-a-financing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ona Therapeutics | Ona Therapeutics raises \u20ac30M in Series A financing\" \/>\n<meta property=\"og:description\" content=\"Barcelona, Spain, June 16th 2020: \u00a0Ona Therapeutics, which is focused on the discovery and development of therapeutic biologics to treat metastatic cancer,\u00a0 announces today the closing of a \u20ac30 million Series A financing, with participation from existing investor Asabys Partners and new investors Alta Life Sciences, Bpifrance \u2013 InnoBio 2, Fund+ and Ysios Capital. See […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-raises-e30m-in-series-a-financing\/\" \/>\n<meta property=\"og:site_name\" content=\"Ona Therapeutics\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-07T19:09:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-content\/uploads\/2024\/05\/logo.png\" \/>\n\t<meta property=\"og:image:width\" content=\"968\" \/>\n\t<meta property=\"og:image:height\" content=\"440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@onatherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/press-release\\\/ona-therapeutics-raises-e30m-in-series-a-financing\\\/\",\"url\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/press-release\\\/ona-therapeutics-raises-e30m-in-series-a-financing\\\/\",\"name\":\"Ona Therapeutics | Ona Therapeutics raises \u20ac30M in Series A financing\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/#website\"},\"datePublished\":\"2020-06-16T22:49:32+00:00\",\"dateModified\":\"2024-05-07T19:09:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/press-release\\\/ona-therapeutics-raises-e30m-in-series-a-financing\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/press-release\\\/ona-therapeutics-raises-e30m-in-series-a-financing\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/press-release\\\/ona-therapeutics-raises-e30m-in-series-a-financing\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ona Therapeutics raises \u20ac30M in Series A financing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/#website\",\"url\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/\",\"name\":\"Ona Therapeutics\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/#organization\",\"name\":\"Ona Therapeutics\",\"url\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/logo.png\",\"width\":968,\"height\":440,\"caption\":\"Ona Therapeutics\"},\"image\":{\"@id\":\"https:\\\/\\\/ona-therapeutics.com\\\/website_f8a3cb38\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/onatherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ona-therapeutics\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ona Therapeutics | Ona Therapeutics raises \u20ac30M in Series A financing","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-raises-e30m-in-series-a-financing\/","og_locale":"en_US","og_type":"article","og_title":"Ona Therapeutics | Ona Therapeutics raises \u20ac30M in Series A financing","og_description":"Barcelona, Spain, June 16th 2020: \u00a0Ona Therapeutics, which is focused on the discovery and development of therapeutic biologics to treat metastatic cancer,\u00a0 announces today the closing of a \u20ac30 million Series A financing, with participation from existing investor Asabys Partners and new investors Alta Life Sciences, Bpifrance \u2013 InnoBio 2, Fund+ and Ysios Capital. See […]","og_url":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-raises-e30m-in-series-a-financing\/","og_site_name":"Ona Therapeutics","article_modified_time":"2024-05-07T19:09:06+00:00","og_image":[{"width":968,"height":440,"url":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-content\/uploads\/2024\/05\/logo.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@onatherapeutics","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-raises-e30m-in-series-a-financing\/","url":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-raises-e30m-in-series-a-financing\/","name":"Ona Therapeutics | Ona Therapeutics raises \u20ac30M in Series A financing","isPartOf":{"@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/#website"},"datePublished":"2020-06-16T22:49:32+00:00","dateModified":"2024-05-07T19:09:06+00:00","breadcrumb":{"@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-raises-e30m-in-series-a-financing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-raises-e30m-in-series-a-financing\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/press-release\/ona-therapeutics-raises-e30m-in-series-a-financing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/"},{"@type":"ListItem","position":2,"name":"Ona Therapeutics raises \u20ac30M in Series A financing"}]},{"@type":"WebSite","@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/#website","url":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/","name":"Ona Therapeutics","description":"","publisher":{"@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/#organization","name":"Ona Therapeutics","url":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/#\/schema\/logo\/image\/","url":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-content\/uploads\/2024\/05\/logo.png","contentUrl":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-content\/uploads\/2024\/05\/logo.png","width":968,"height":440,"caption":"Ona Therapeutics"},"image":{"@id":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/onatherapeutics","https:\/\/www.linkedin.com\/company\/ona-therapeutics\/"]}]}},"_links":{"self":[{"href":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-json\/wp\/v2\/press-release\/317","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-json\/wp\/v2\/press-release"}],"about":[{"href":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-json\/wp\/v2\/types\/press-release"}],"wp:attachment":[{"href":"https:\/\/ona-therapeutics.com\/website_f8a3cb38\/wp-json\/wp\/v2\/media?parent=317"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}